MicroRNAs as regulators of tumor-associated stromal cells
MicroRNAs as regulators of tumor-associated stromal cells |
|
https://doi.org/10.18632/oncotarget.1625
Brian Ell,
and Yibin Kang
|
| 2166-2167 |
MYC and MiR: vicious circle
MYC and MiR: vicious circle |
|
https://doi.org/10.18632/oncotarget.1602
Xiaohong Zhao,
Xinwei Zhang,
and Jianguo Tao
|
| 2168-2169 |
Wip1 and ATM in tumor evolution: role for BRCA1.
Wip1 and ATM in tumor evolution: role for BRCA1. |
|
https://doi.org/10.18632/oncotarget.1661
Doria Filipponi,
and Dmitry V. Bulavin
|
| 2170 |
Chemokines in tumor progression and metastasis
Chemokines in tumor progression and metastasis |
|
https://doi.org/10.18632/oncotarget.1426
Purvaba J. Sarvaiya,
Donna Guo,
Ilya V. Ulasov,
Patrik Gabikian,
and Maciej S. Lesniak
|
| 2171-2185 |
Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms
Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms |
|
https://doi.org/10.18632/oncotarget.1497
Jahangir Abdi,
Guoan Chen,
and Hong Chang
|
| 2186-2207 |
A loss-of-function mutation in PTCH1 suggests a role for autocrine hedgehog signaling in colorectal tumorigenesis
A loss-of-function mutation in PTCH1 suggests a role for autocrine hedgehog signaling in colorectal tumorigenesis |
|
https://doi.org/10.18632/oncotarget.1651
Jon H. Chung,
and Fred Bunz
|
| 2208-2211 |
Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype.
Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype. |
|
https://doi.org/10.18632/oncotarget.1143
Mickaël Ohanna,
Yann Cheli,
Caroline Bonet,
Vanessa F Bonazzi,
Marylin Allegra,
Sandy Giuliano,
Karine Bille,
Philippe Bahadoran,
Damien Giacchero,
Jean Philippe Lacour,
Glen M Boyle,
Nicholas F Hayward,
Corine Bertolotto,
and Robert Ballotti
|
| 2212-2224 |
Combinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate cancer
Combinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate cancer |
|
https://doi.org/10.18632/oncotarget.1314
Leigh Ellis,
ShengYu Ku,
Swathi Ramakrishnan,
Elena Lasorsa,
Gizzou Azabdaftari,
Alejandro Godoy,
and Roberto Pili
|
| 2225-2236 |
Identification of anaplastic lymphoma kinase as a potential therapeutic target in Basal Cell Carcinoma
Identification of anaplastic lymphoma kinase as a potential therapeutic target in Basal Cell Carcinoma |
|
https://doi.org/10.18632/oncotarget.1357
Hanna Ning,
Hiroshi Mitsui,
Claire Q.F. Wang,
Mayte Suárez-Fariñas,
Juana Gonzalez,
Kejal R. Shah,
Jie Chen,
Israel Coats,
Diane Felsen,
John A. Carucci,
and James G. Krueger
|
| 2237-2248 |
Induction of apoptosis by directing oncogenic Bcr-Abl into the nucleus
Induction of apoptosis by directing oncogenic Bcr-Abl into the nucleus |
|
https://doi.org/10.18632/oncotarget.1339
Zheng-Lan Huang,
Miao Gao,
Qian-Yin Li,
Kun Tao,
Qing Xiao,
Wei-Xi Cao,
and Wen-Li Feng
|
| 2249-2260 |
Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma
Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma |
|
https://doi.org/10.18632/oncotarget.1302
Yoshinari Shinsato,
Tatsuhiko Furukawa,
Shunji Yunoue,
Hajime Yonezawa,
Kentarou Minami,
Yukihiko Nishizawa,
Ryuji Ikeda,
Kohichi Kawahara,
Masatatsu Yamamoto,
Hirofumi Hirano,
Hiroshi Tokimura,
and Kazunori Arita
|
| 2261-2270 |
A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines
A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines |
|
https://doi.org/10.18632/oncotarget.1403
Ilaria Sciamanna,
Alberto Gualtieri,
Cristina Cossetti,
Emanuele Felice Osimo,
Manuela Ferracin,
Gianfranco Macchia,
Eleonora Arico,
Gianni Prosseda,
Patrizia Vitullo,
Tom Misteli,
and Corrado Spadafora
|
| 2271-2287 |
A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors
A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors |
|
https://doi.org/10.18632/oncotarget.1376
Emilia Mira,
Lorena Carmona-Rodríguez,
Manuel Tardáguila,
Iñigo Azcoitia,
Alicia González-Martín,
Luis Almonacid,
Josefina Casas,
Gemma Fabriás,
and Santos Mañes
|
| 2288-2301 |
Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5
Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5 |
|
https://doi.org/10.18632/oncotarget.1490
Prisca Exertier,
Sophie Javerzat,
Baigang Wang,
Mélanie Franco,
John M. Herbert,
Natalia Platonova,
Marie Winandy,
Nadège Pujol,
Olivier Nivelles,
Sandra Ormenese,
Virginie Godard,
Jürgen Becker,
Roy Bicknell,
Raphael Pineau,
Jörg Wilting,
Andreas Bikfalvi,
and Martin Hagedorn
|
| 2302-2316 |
HOXA11 hypermethylation is associated with progression of non-small cell lung cancer
HOXA11 hypermethylation is associated with progression of non-small cell lung cancer |
|
https://doi.org/10.18632/oncotarget.1464
Jung-Ah Hwang,
Bo Bin Lee,
Yujin Kim,
Seong-Eun Park,
Kyun Heo,
Seung-Hyun Hong,
Young-Ho Kim,
Joungho Han,
Duk-Hwan Kim,
Young Mog Shim,
and Yeon-Su Lee
|
| 2317-2325 |
Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity
Enrichment of human osteosarcoma stem cells based on hTERT transcriptional activity |
|
https://doi.org/10.18632/oncotarget.1554
Ling Yu,
Shiqing Liu,
Chun Zhang,
Bo Zhang,
Bruno M. Simoes,
Rachel Eyre,
Yi Liang,
Huichao Yan,
Zheng Wu,
Weichun Guo,
and Robert B. Clarke
|
| 2326-2338 |
SCFβ-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration
SCFβ-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration |
|
https://doi.org/10.18632/oncotarget.1446
Jiateng Zhong,
Shavali Shaik,
Lixin Wan,
Adriana E. Tron,
Zhiwei Wang,
Liankun Sun,
Hiroyuki Inuzuka,
and Wenyi Wei
|
| 2339-2353 |
Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis
Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis |
|
https://doi.org/10.18632/oncotarget.1422
Alejandra M. Petrilli,
Marga Bott,
and Cristina Fernández-Valle
|
| 2354-2365 |
Ovarian cancer stem-like cells with induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor
Ovarian cancer stem-like cells with induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor |
|
https://doi.org/10.18632/oncotarget.1424
Kuei-Chun Liu,
Yi-Te Yo,
Rui-Lan Huang,
Yu-Chi Wang,
Yu-Ping Liao,
Tien-Shuo Huang,
Tai-Kuang Chao,
Chi-Kang Lin,
Shao-Ju Weng,
Kuo-Hsing Ma,
Cheng-Chang Chang,
Mu-Hsien Yu,
and Hung-Cheng Lai
|
| 2366-2382 |
EI24 regulates epithelial-to-mesenchymal transition and tumor progression by suppressing TRAF2-mediated NF-κB activity
EI24 regulates epithelial-to-mesenchymal transition and tumor progression by suppressing TRAF2-mediated NF-κB activity |
|
https://doi.org/10.18632/oncotarget.1434
Jung-Min Choi,
Sushil Devkota,
Young Hoon Sung,
and Han-Woong Lee
|
| 2383-2396 |
1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer
1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer |
|
https://doi.org/10.18632/oncotarget.1494
Jong-Wei Hsu,
Peng-Nien Yin,
Ronald Wood,
James Messing,
Edward Messing,
and Yi-Fen Lee
|
| 2397-2406 |
In situ mutation detection and visualization of intratumor heterogeneity for cancer research and diagnostics
In situ mutation detection and visualization of intratumor heterogeneity for cancer research and diagnostics |
|
https://doi.org/10.18632/oncotarget.1527
Ida Grundberg,
Sara Kiflemariam,
Marco Mignardi,
Juliana Imgenberg-Kreuz,
Karolina Edlund,
Patrick Micke,
Magnus Sundström,
Tobias Sjöblom,
Johan Botling,
and Mats Nilsson
|
| 2407-2418 |
Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.
Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer. |
|
https://doi.org/10.18632/oncotarget.1572
Anastasia Wyce,
Yan Degenhardt,
Yuchen Bai,
BaoChau Le,
Susan Korenchuk,
Ming-Chih Crouthamel,
Charles McHugh,
Robert Vessella,
Caretha Creasy,
Peter Tummino,
and Olena Barbash
|
| 2419-2429 |
Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells
Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells |
|
https://doi.org/10.18632/oncotarget.1431
Kai Wu,
Qingshan Chang,
Yongju Lu,
Ping Qiu,
Bailing Chen,
Chitra Thakur,
Jiaying Sun,
Lingzhi Li,
Anjaneyulu Kowluru,
and Fei Chen
|
| 2430-2438 |
Evaluation of Zinc (II) chelators for inhibiting p53-mediated apoptosis
Evaluation of Zinc (II) chelators for inhibiting p53-mediated apoptosis |
|
https://doi.org/10.18632/oncotarget.1535
Akinori Morita,
Shinya Ariyasu,
Soichiro Ohya,
Ippei Takahashi,
Bing Wang,
Kaoru Tanaka,
Takatoshi Uchida,
Haruna Okazaki,
Kengo Hanaya,
Atsushi Enomoto,
Mitsuru Nenoi,
Masahiko Ikekita,
Shin Aoki,
and Yoshio Hosoi
|
| 2439-2450 |
Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer
Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer |
|
https://doi.org/10.18632/oncotarget.1586
Luigi Fontana,
Remi M. Adelaiye,
Antonella L. Rastelli,
Kiersten Marie Miles,
Eric Ciamporcero,
Valter D. Longo,
Holly Nguyen,
Robert Vessella,
and Roberto Pili
|
| 2451-2461 |
High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer
High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer |
|
https://doi.org/10.18632/oncotarget.1578
Shuyan Liu,
and Pengsheng Zheng
|
| 2462-2475 |
FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7
FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7 |
|
https://doi.org/10.18632/oncotarget.1581
Zeran Wang,
Yueyong Liu,
Pengju Zhang,
Weiguo Zhang,
Weijing Wang,
Kenneth Curr,
Guangwei Wei,
and Jian-Hua Mao
|
| 2476-2486 |
Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects
Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects |
|
https://doi.org/10.18632/oncotarget.1604
Jason U. Tilan,
Congyi Lu,
Susana Galli,
Ewa Izycka-Swieszewska,
Joshua P. Earnest,
Asim Shabbir,
Lindsay M. Everhart,
Shuo Wang,
Samantha Martin,
Meredith Horton,
Akanksha Mahajan,
David Christian,
Alison O'Neill,
Hongkun Wang,
Tingting Zhuang,
Magdalena Czarnecka,
Michael D. Johnson,
Jeffrey A. Toretsky,
and Joanna B. Kitlinska
|
| 2487-2501 |
Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth
Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth |
|
https://doi.org/10.18632/oncotarget.1540
Jinyun Chen,
Franklin Chung,
Guizhi Yang,
Minying Pu,
Hui Gao,
Wei Jiang,
Hong Yin,
Vladimir Capka,
Shailaja Kasibhatla,
Bryan Laffitte,
Savina Jaeger,
Raymond Pagliarini,
Yaoyu Chen,
and Wenlai Zhou
|
| 2502-2511 |
Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer
Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer |
|
https://doi.org/10.18632/oncotarget.1463
Gab-Yong Bae,
So-Jung Choi,
Ji-Seon Lee,
Jisuk Jo,
Jinseon Lee,
Jhingook Kim,
and Hyuk-Jin Cha
|
| 2512-2522 |
Extracellular p53 fragment re-enters K-Ras mutated cells through the caveolin-1 dependent early endosomal system
Extracellular p53 fragment re-enters K-Ras mutated cells through the caveolin-1 dependent early endosomal system |
|
https://doi.org/10.18632/oncotarget.1550
Sun-Hye Lee,
Tae-Gyun Woo,
Su-Jin Lee,
Nam-Chul Ha,
and Bum-Joon Park
|
| 2523-2531 |
The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer
The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer |
|
https://doi.org/10.18632/oncotarget.1503
Zhongwu li,
Yanling Wang,
Jing Qiu,
Qiang Li,
Chunping Yuan,
Wei Zhang,
Dongmiao Wang,
Jinhai Ye,
Hongbin Jiang,
Jianrong Yang,
and Jie Cheng
|
| 2532-2549 |
Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming
Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming |
|
https://doi.org/10.18632/oncotarget.1508
Veronica Martinez-Marignac,
Nader Toban,
Miguel Bazile,
and Raquel Aloyz
|
| 2550-2566 |
Endothelial hypoxic metabolism in carcinogenesis and dissemination : HIF-A isoforms are a NO metastatic phenomenon
Endothelial hypoxic metabolism in carcinogenesis and dissemination : HIF-A isoforms are a NO metastatic phenomenon |
|
https://doi.org/10.18632/oncotarget.1461
Cristina Branco-Price,
Colin E. Evans,
and Randall S. Johnson
|
| 2567-2576 |
Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers
Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers |
|
https://doi.org/10.18632/oncotarget.1658
Barak Rotblat,
Thomas G. P. Grunewald,
Gabriel Leprivier,
Gerry Melino,
and Richard A. Knight
|
| 2577-2590 |
